Real-Word Performance of DOAC Dipstick and DOASENSE Reader in Patients on Direct Oral Anticoagulant (DOAC) Therapy.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030502

Enrollment

120

Registered

2022-12-05

Start date

2022-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z92.1

Interventions

Group 1: Urine and blood samples will be collected from patients treated with DOAC and DOAC levels will be compared between DOAC levels measured in the laboratory and DOAC levels measured with DOASENS

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients treated with direct oral anticoagulants (n=100) Control group (n=20) without therapy with direct oral anticoagulants Body weight over 50kg Minimum age 18 years

Exclusion criteria

Exclusion criteria: Children and adolescents Underweight (under 50kg)

Design outcomes

Primary

Measure	Time frame
Measurement of DOAC levels in urine and blood	—

Secondary

Measure	Time frame
Calculation of positive and negative predictive values of DOAC dipstick.	—

Countries

Germany

Contacts

Public ContactGunalp Uzun

Institut für klinische und experimentelle Transfusionsmedizin

guenalp.uzun@med.uni-tuebingen.de07071/2981617

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026